Squeeze Report — June 30, 2026
Biotech dominates today's high-conviction squeeze list, with BEAM and ORKA leading a cluster of clinical-stage names where surging short interest is colliding with imminent data readouts. Outside the sector, FRMM's 95% short-interest spike and LION's blockbuster-fueled rally stand out as the most combustible non-biotech setups.
Today's top short-squeeze candidates
- #1ORICOric Pharmaceuticals, Inc. Com82
43% of float sold short · 10.3 days to cover · +20% over 20 days
SI 43%DTC 10.3$10.15+20% 20dHealthcare - #2AVTXAvalo Therapeutics, Inc. Commo82
68% of float sold short · 5.5 days to cover · +21% over 20 days
SI 68%DTC 5.5$19.29+21% 20dHealthcare - #3CRVSCorvus Pharmaceuticals, Inc. C81
14 days to cover and insider buying are tempting, but a $200M ATM shelf keeps a lid on squeeze conviction.
SI 25%DTC 14.4$14.48+17% 20dHealthcare - #4ORKAOruka Therapeutics, Inc. Commo81
Flat price near highs with 26% short interest means any positive EVERLAST-A data could force a rapid cover.
SI 26%DTC 6.1$92.49+58% 20dHealthcare - #5CADLCandel Therapeutics, Inc. Comm80
29% of float sold short · 7.6 days to cover · +25% over 20 days
SI 29%DTC 7.6$10.36+25% 20dHealthcare - #6GOGrocery Outlet Holding Corp. C79
28% of float sold short · 10.6 days to cover · +14% over 20 days
SI 28%DTC 10.6$9.72+14% 20dConsumer Defensive - #7VERAVera Therapeutics, Inc. Class78
20% of float sold short · 10.4 days to cover · +21% over 20 days
SI 20%DTC 10.4$43.15+21% 20dHealthcare - #8CERTCertara, Inc. Common Stock78
A $100M buyback is shrinking the float while shorts press a 53% drawdown, making Q2 earnings a potential inflection.
SI 27%DTC 7.3$6.36+9% 20dHealthcare - #9LIONLionsgate Studios Corp.78
Record trailing library revenue and a Michael biopic haven't deterred shorts, setting up a squeeze into August earnings.
SI 44%DTC 5.7$15.63+9% 20dCommunication Services - #10RZLTRezolute, Inc. Common Stock (N78
21% of float sold short · 5.4 days to cover · +55% over 20 days
SI 21%DTC 5.4$5.10+55% 20dHealthcare - #11REPLReplimune Group, Inc. Common S77
30% of float sold short · 4.8 days to cover · +29% over 20 days
SI 30%DTC 4.8$11.20+29% 20dHealthcare - #12GPGIGPGI, Inc.77
A 28% surge on stale data likely covered most shorts; the doubling of shares outstanding makes a re-squeeze improbable.
SI 36%DTC 18.1$15.54+28% 20dIndustrials - #13SGMTSagimet Biosciences Inc. Serie77
A near-doubling of shares outstanding dilutes the 19% short interest, making this a lower-conviction biotech play.
SI 19%DTC 9.0$7.79+7% 20dHealthcare - #14PTCTPTC Therapeutics, Inc. Common76
16% of float sold short · 7.8 days to cover · +10% over 20 days
SI 16%DTC 7.8$81.57+10% 20dHealthcare - #15LQDALiquidia Corporation Common St76
19% of float sold short · 5.1 days to cover · +21% over 20 days
SI 19%DTC 5.1$75.12+21% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →